Control of glycolysis through regulation of PFK1: Old friends and recent additions

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 76, Issue , 2011, Pages 211-216

  Mor, I ^a   Cheung, E C ^a   Vousden, K H ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; FRUCTOSE 2,6 BISPHOSPHATE; GLUCOSE; GLUCOSE 6 PHOSPHATE; GLYCOGEN; INSULIN; LACTIC ACID; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; PROTEIN P53;

ACTIN FILAMENT; ADIPOSE TISSUE; ALLOSTERISM; ARTICLE; CANCER CELL; CELL CYCLE; CELL METABOLISM; CELL PROLIFERATION; CYTOSKELETON; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; GLYCOLYSIS; HORMONAL REGULATION; METABOLIC REGULATION; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; APOPTOSIS; HUMAN; ONCOGENE; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELLS; FRUCTOSEDIPHOSPHATES; GLYCOLYSIS; HUMANS; NEOPLASMS; PHOSPHOFRUCTOKINASE-1;

EID: 84867425035     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2011.76.010868     Document Type: Article

References (42)

1. Almeida A, Bolanos JP, Moncada S. 2010. E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc Natl Acad Sci 107: 738-741.
2. Atsumi T, Chesney J, Metz C, Leng L, Donnelly S, Makita Z, Mitchell R, Bucala R. 2002. High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res 62: 5881-5887.
3. Atsumi T, Nishio T, Niwa H, Takeuchi J, Bando H, Shimizu C, Yoshioka N, Bucala R, Koike T. 2005. Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation. Diabetes 54: 3349-3357.
4. Bando H, Atsumi T, Nishio T, Niwa H, Mishima S, Shimizu C, Yoshioka N, Bucala R, Koike T. 2005. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Clin Cancer Res 11: 5784-5792.
5. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH. 2006. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120.
6. Bensaad K, Cheung EC, Vousden KH. 2009. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J 28: 3015-3026.
7. Bosca L, Mojena M, Ghysdael J, Rousseau GG, Hue L. 1986. Expression of the v-src or v-fps oncogene increases fructose 2,6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses. Biochem J 236: 595-599.
8. Calvo MN, Bartrons R, Castano E, Perales JC, Navarro-Sabate A, Manzano A. 2006. PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells. FEBS Lett 580: 3308-3314.
9. Chesney J, Mitchell R, Benigni F, Bacher M, Spiegel L, Al-Abed Y, Han JH, Metz C, Bucala R. 1999. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: Role in tumor cell glycolysis and theWarburg effect. Proc Natl Acad Sci 96: 3047-3052.
10. Clem B, Telang S, Clem A, Yalcin A, Meier J, Simmons A, Rasku MA, Arumugam S, Dean WL, Eaton J, et al. 2008. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 7: 110-120.
11. Costa Leite T, Da Silva D, Guimaraes Coelho R, Zancan P, Sola-Penna M. 2007. Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1-kinase tetramers down-regulating the enzyme and muscle glycolysis. Biochem J 408: 123-130.
12. Derdak Z, Lang CH, Villegas KA, Tong M, Mark NM, de la Monte SM, Wands JR. 2011. Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease. J Hepatol 54: 164-172.
13. Donthi RV, Ye G, Wu C, McClain DA, Lange AJ, Epstein PN. 2004. Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity. J Biol Chem 279: 48085-48090.
14. Garcia M, Pujol A, Ruzo A, Riu E, Ruberte J, Arbos A, Serafin A, Albella B, Feliu JE, Bosch F. 2009. Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis. PLoS Genet 5: e1000615.
15. Haller RG, Lewis SF. 1991. Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. New Engl J Med 324: 364-369.
16. Herrero-Mendez A, Almeida A, Fernandez E, Maestre C, Moncada S, Bolanos JP. 2009. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 11: 747-752.
17. Hers HG, Van Schaftingen E. 1982. Fructose 2,6-bisphosphate 2 years after its discovery. Biochem J 206: 1-12.
18. Huo Y, Guo X, Li H, Wang H, ZhangW, Wang Y, Zhou H, Gao Z, Telang S, Chesney J, et al. 2010. Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response. J Biol Chem 285: 3713-3721.
19. Jenkins CM, Yang J, Sims HF, GrossRW. 2011. Reversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: A mechanism integrating glycolytic flux with lipid metabolism. J Biol Chem 286: 11937-11950.
20. Kessler R, Bleichert F, Warnke JP, Eschrich K. 2008. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas. J Neurooncol 86: 257-264.
21. Kimata M, Matoba S, Iwai-Kanai E, Nakamura H, Hoshino A, Nakaoka M, Katamura M, Okawa Y, Mita Y, Okigaki M, et al. 2010. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress. Am J Physiol Heart Circul Physiol 299: H1908-H1916.
22. Kole HK, Resnick RJ, Van Doren M, Racker E. 1991. Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts. Arch Biochem Biophys 286: 586-590.
23. Li H, Jogl G. 2009. Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator). J Biol Chem 284: 1748-1754.
24. Lui VW, Lau CP, Cheung CS, Ho K, Ng MH, Cheng SH, Hong B, Tsao SW, Tsang CM, Lei KI, et al. 2010. An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-b-D-ribo-pentofuranosyl) cytosine (ECyd), elicits antitumor effect via TP53-induced glycolysis and apoptosis regulator (TIGAR) downregulation. Biochem Pharmacol 79: 1772-1780.
25. Lui VW, Wong EY, Ho K, Ng PK, Lau CP, Tsui SK, Tsang CM, Tsao SW, Cheng SH, Ng MH, et al. 2011. Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death. Oncogene 30: 1127-1134.
26. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, Hue L. 2000. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 10: 1247-1255.
27. Marsin AS, Bouzin C, Bertrand L, Hue L. 2002. The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J Biol Chem 277: 30778-30783.
28. Minchenko O, Opentanova I, Caro J. 2003. Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett 554: 264-270.
29. Moon JS, Jin WJ, Kwak JH, Kim HJ, Yun MJ, Kim JW, Park SW, Kim KS. 2010. Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells. Biochem J 433: 225-233.
30. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E. 2007. Energy metabolism in tumor cells. FEBS J 274: 1393-1418.
31. Mukhtar MH, Payne VA, Arden C, Harbottle A, Khan S, Lange AJ, Agius L. 2008. Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Am J Physiol Regul Integr Comp Physiol 294: R766-R774.
32. Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, Lange AJ. 2001. PFK-2/FBPase-2: Maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 26: 30-35.
33. Raben N, Sherman JB. 1995. Mutations in muscle phosphofructokinase gene. Hum Mutat 6: 1-6.
34. Real-Hohn A, Zancan P, Da Silva D, Martins ER, Salgado LT, Mermelstein CS, Gomes AM, Sola-Penna M. 2010. Filamentous actin and its associated binding proteins are the stimulatory site for 6-phosphofructo-1-kinase association within the membrane of human erythrocytes. Biochimie 92: 538-544.
35. Rider MH, Bertrand L, Vertommen D, Michels PA, Rousseau GG, Hue L. 2004. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: Head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J 381: 561-579.
36. Telang S, Yalcin A, Clem AL, Bucala R, Lane AN, Eaton JW, Chesney J. 2006. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene 25: 7225-7234.
37. Tudzarova S, Colombo SL, Stoeber K, Carcamo S, Williams GH, Moncada S. 2011. Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-β-TrCP, sequentially regulate glycolysis during the cell cycle. Proc Natl Acad Sci 108: 5278-5283.
38. Warburg O. 1956. On the origin of cancer cells. Science 123: 309-314.
39. Weber G. 1977. Enzymology of cancer cells (second of two parts). New Engl J Med 296: 541-551.
40. Won KY, Lim SJ, Kim GY, Kim YW, Han SA, Song JY, Lee DK. 2011. Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer. Hum Pathol [Epub ahead of print].
41. Yalcin A, Clem BF, Simmons A, Lane A, Nelson K, Clem AL, Brock E, Siow D, Wattenberg B, Telang S, et al. 2009a. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem 284: 24223-24232.
42. Yalcin A, Telang S, Clem B, Chesney J. 2009b. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Exp Mol Pathol 86: 174-179.